Evidence map›Paper›PMID 39337688›Full record

SynthesisInternational journal of molecular sciences2024

Follicular Skin Disorders, Inflammatory Bowel Disease, and the Microbiome: A Systematic Review.

Lauren Fleshner, Katie Roster, Banu Farabi, Rahim Hirani, Katharine Tepper, Capecomorin S Pitchumoni, Bijan Safai, Shoshana Marmon

Abstract readSystematic Review
In one paragraph

Synthesis in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Insights into intestinal barrier disruption during long-term gutFrontiers in cellular and infection microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lauren FleshnerSchool of Medicine, New York Medical College, Valhalla, NY 10595, USA.ORCID 0000-0001-8534-6999
Katie RosterDermatology Department, Georgetown University School of Medicine, Medstar Washington Hospital Center, Washington, DC 20007, USA.
Banu FarabiSchool of Medicine, New York Medical College, Valhalla, NY 10595, USA.ORCID 0000-0002-4748-1556
Rahim HiraniSchool of Medicine, New York Medical College, Valhalla, NY 10595, USA.ORCID 0000-0002-9304-9916
Katharine TepperSchool of Medicine, New York Medical College, Valhalla, NY 10595, USA.ORCID 0009-0002-4633-3997
Capecomorin S PitchumoniSchool of Medicine, New York Medical College, Valhalla, NY 10595, USA.
Bijan SafaiSchool of Medicine, New York Medical College, Valhalla, NY 10595, USA.
Shoshana MarmonSchool of Medicine, New York Medical College, Valhalla, NY 10595, USA.ORCID 0000-0002-8489-961X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Follicular skin disorders, including hidradenitis suppurativa (HS), frequently coexist with systemic autoinflammatory diseases, such as inflammatory bowel disease (IBD) and its subtypes, Crohn's disease and ulcerative colitis. Previous studies suggest that dysbiosis of the human gut microbiome may serve as a pathogenic link between HS and IBD. However, the role of the microbiome (gut, skin, and blood) in the context of IBD and various follicular disorders remains underexplored. Here, we performed a systematic review to investigate the relationship between follicular skin disorders, IBD, and the microbiome. Of the sixteen included studies, four evaluated the impact of diet on the microbiome in HS patients, highlighting a possible link between gut dysbiosis and yeast-exclusion diets. Ten studies explored bacterial colonization and HS severity with specific gut and skin microbiota, including Enterococcus and Veillonella. Two studies reported on immunological or serological biomarkers in HS patients with autoinflammatory disease, including IBD, and identified common markers including elevated cytokines and T-lymphocytes. Six studies investigated HS and IBD patients concurrently. Our systematic literature review highlights the complex interplay between the human microbiome, IBD, and follicular disorders with a particular focus on HS. The results indicate that dietary modifications hold promise as a therapeutic intervention to mitigate the burden of HS and IBD. Microbiota analyses and the identification of key serological biomarkers are crucial for a deeper understanding of the impact of dysbiosis in these conditions. Future research is needed to more thoroughly delineate the causal versus associative roles of dysbiosis in patients with both follicular disorders and IBD.

Indexed as

DysbiosisGastrointestinal MicrobiomeInflammatory Bowel DiseasesHidradenitis SuppurativaHumansMicrobiotaSkinSkin Diseasesdysbiosisfollicular disordersgut floragut–skin axishidradenitis suppurativahuman microbiomeimmune systeminflammatory bowel diseaseskin diseasesystematic review

Identifiers

PMID39337688
PMCPMC11431962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.